beta

AMAG

AMAG Pharmaceuticals Inc.

Amag

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

AMAG Pharmaceuticals Inc is a biopharmaceutical company, which utilizes the technology for the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and to aid in the diagnosis of cancer.

Market Cap: 518 Million

Primary Exchange: Nasdaq Global Select

Website: http://www.amagpharma.com

Shares Outstanding: 35.4 Million

Float: 34 Million

Dividend: 0.0 (0.0%)

Beta: 0.826016

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 8.33 Million

Ethical Flags

Animal testing

Longest drawdown: 1068 trading days

From: 2015-07-16 To: 2019-10-18

Lowest Point:

AMAG: Great Value Behind That Not-So-Rosy Growth

via: SeekingAlpha at 2019-06-11 07:45:17:000

Introduction: AMAG Pharmaceuticals ( AMAG ) is a specialty pharmaceuticals company with an emphasis on Women's Health and treatment of Iron Deficiency Anemia. The company's stock has been punished over the past quarter due to the presence of generics taking market share from its key produ… read more...

AMAG: Great Value Behind That Not-So-Rosy Growth

via: SeekingAlpha at 2019-06-11 07:45:17:000

Introduction: AMAG Pharmaceuticals ( AMAG ) is a specialty pharmaceuticals company with an emphasis on Women's Health and treatment of Iron Deficiency Anemia. The company's stock has been punished over the past quarter due to the presence of generics taking market share from its key produ… read more...

AMAG: Great Value Behind That Not-So-Rosy Growth

via: SeekingAlpha at 2019-06-11 07:45:17:000

Introduction: AMAG Pharmaceuticals ( AMAG ) is a specialty pharmaceuticals company with an emphasis on Women's Health and treatment of Iron Deficiency Anemia. The company's stock has been punished over the past quarter due to the presence of generics taking market share from its key produ… read more...

Barclays bearish on Teva, sees 14% downside risk in premarket analyst action

via: SeekingAlpha at 2019-06-11 04:46:44:000

Agilent (NYSE: A ) initiated with Overweight rating and $83 (18% upside) price target at Piper Jaffray. More news on: Agilent Technologies, Inc., Danaher Corporation, Teleflex Incorporated, Healthcare stocks news, Stocks on the move, , Read more … read more...

Barclays bearish on Teva, sees 14% downside risk in premarket analyst action

via: SeekingAlpha at 2019-06-11 04:46:44:000

Agilent (NYSE: A ) initiated with Overweight rating and $83 (18% upside) price target at Piper Jaffray. More news on: Agilent Technologies, Inc., Danaher Corporation, Teleflex Incorporated, Healthcare stocks news, Stocks on the move, , Read more … read more...

Barclays bearish on Teva, sees 14% downside risk in premarket analyst action

via: SeekingAlpha at 2019-06-11 04:46:44:000

Agilent (NYSE: A ) initiated with Overweight rating and $83 (18% upside) price target at Piper Jaffray. More news on: Agilent Technologies, Inc., Danaher Corporation, Teleflex Incorporated, Healthcare stocks news, Stocks on the move, , Read more … read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud